Alebund Pharmaceuticals (Jiangsu) Limited Class H

Alebund Pharmaceuticals (Jiangsu) Limited Class H

HHKEX:9637
19.95
HKD
-0.15
(-0.75%)
15.61BMarket Cap
Mar 03Next Earn

Total Valuation

HKD

As of June 30, 2026, Alebund Pharmaceuticals (Jiangsu) Limited Class H carries a market capitalization of 15.61B, placing it among publicly traded companies globally. Its enterprise value stands at 14.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap15.61B
Enterprise Value14.66B

Important Dates

Alebund Pharmaceuticals (Jiangsu) Limited Class H's next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of June 30, 2026, Alebund Pharmaceuticals (Jiangsu) Limited Class H has 339.85M shares outstanding.

Shares Outstanding339.85M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio9.59
P/TBV Ratio9.65

Financial Position

As of June 30, 2026, Alebund Pharmaceuticals (Jiangsu) Limited Class H maintains a current ratio of 9.81, meaning it holds 9.8x the short-term assets needed to cover near-term liabilities.

Current Ratio9.81
Quick Ratio9.65
Debt / Equity40.94

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count162.00

Stock Price Statistics

HKD

These figures are as of the close on November 17, 2026.

50-Day Moving Average21.96

Balance Sheet

HKD

As of June 30, 2026, Alebund Pharmaceuticals (Jiangsu) Limited Class H holds 1.61B in cash and equivalents against 666.47M in total debt, resulting in a net debt position of -890.83M. Total book value stands at 1.63B, with working capital of 1.47B providing operational flexibility.

Cash & Cash Equivalents1.61B
Total Debt666.47M
Net Debt-890.83M
Equity (Book Value)1.63B
Book Value Per Share4.79
Working Capital1.47B